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Secreted factors play a central role in normal andpathological processes in every tissue in the body. The brain is composed of a highly complex
milieu of different cell types and fewmethods exist that can identifywhich individual cells in a complexmixture are secreting specific analytes.
By identifyingwhich cells are responsible,we canbetter understandneural physiology andpathophysiology,more readily identify theunderly-
ing pathways responsible for analyte production, and ultimately use this information to guide the development of novel therapeutic strategies
that target thecell typesof relevance.Wepresenthereamethod fordetectinganalytes secreted fromsinglehuman inducedpluripotent stemcell
(iPSC)-derived neural cells and have applied the method to measure amyloid  (A) and soluble amyloid precursor protein-alpha (sAPP),
analytes central toAlzheimer’sdiseasepathogenesis. Through these studies,wehaveuncovered thedynamic rangeof secretionprofilesof these
analytes from single iPSC-derived neuronal and glial cells and havemolecularly characterized subpopulations of these cells through immuno-
staining and gene expression analyses. In examiningA and sAPP secretion from single cells, wewere able to identify previously unappreci-
ated complexities in the biology of APP cleavage that could not otherwise have been found by studying averaged responses over pools of cells.
This technique can be readily adapted to the detection of other analytes secreted by neural cells, which would have the potential to open new
perspectives into humanCNSdevelopment and dysfunction.
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Introduction
In many neurodegenerative disorders, select populations of neu-
rons are vulnerable whereas others are unaffected. The biological
bases for these selective vulnerabilities are not understood, in part
because the field has lacked reliable high-throughputmethods for
analyzing human neuronal and glial function at the single-cell
level. In the case of a subset of neurodegenerative disorders such
as Alzheimer’s disease (AD), there is growing evidence that neu-
rotoxic species released from cells may underlie pathology. Here,
we have developed a methodology to examine secreted products
relevant to AD from single cells and adapted this method to ex-
amine human neuronal and glial cells derived from induced plu-
ripotent stem cells (iPSCs).
The cellular pathology of AD involves the accumulation of
extracellular deposits composed of amyloid -protein (A) and in-
traneuronal tangles consisting of hyperphosphorylated tau protein
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Significance Statement
We have established a technology that, for the first time, detects secreted analytes from single human neurons and astrocytes. We
examinesecretionof theAlzheimer’sdisease-relevant factorsamyloid (A)andsolubleamyloidprecursorprotein-alpha(sAPP)and
present novel findings that could not have been observedwithout a single-cell analytical platform. First, we identify a previously unap-
preciated subpopulation that secretes high levels of A in the absence of detectable sAPP. Further, we show that multiple cell types
secrete high levels of A and sAPP, but cells expressing GABAergic neuronal markers are overrepresented. Finally, we show that
astrocytes are competent to secrete high levels of A and thereforemay be a significant contributor toA accumulation in the brain.
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(Hardy and Selkoe, 2002).Mutations in presenilin (PSEN1, PSEN2)
oramyloidprecursorprotein(APP)causeanearly-onset formofAD
(Bertram et al., 2010). APP encodes the precursor protein of A and
PSEN encodes the catalytic site of an intramembrane protease that
cleavesAPP to generateA (-secretase).APPalso canbe cleavedby
-secretase to generate soluble amyloid precursor protein-alpha
(sAPP), which precludes A generation from the same molecule.
Genetic, neuropathological, and biomarker findings place A in a
key, early role in AD pathogenesis. Decades of intensive research
have focused on the biochemistry of A generation by sequential
cleavages of APP. However, much of this work was performed in
heterologous cell lines such asHEK,COS, orChinese hamster ovary
(CHO)cells andwithmethods that required the analysis of averaged
responses of large pools of these cells. Although APP cleavage has
been studied extensively, basic information about the dynamics of
APP cleavage and A secretion in different cell types is not known.
Microengraving involves culturing cells in a dense array of
nanowells to quantify multiple secreted analytes and correlate
these measurements with cell intrinsic data from a large number
of single cells (104–105 per array; Love et al., 2006). Relative to
existing techniques, microengraving has three major advantages:
(1) high sensitivity for products secreted from single cells, (2)
potential for a large number of traits evaluated for each cell, and
(3) simultaneous analysis of a large number of cells, which allows
for the detection and interrogation of rare cell populations.
Adaption of this validated platform for neuroscience research
provides a powerful and unique single-cell technology for the
field. Although microengraving was first developed to study the
secretion of antibodies and cytokines from cells of the immune
system (Love et al., 2006; Story et al., 2008; Ogunniyi et al., 2009;
Han et al., 2010), the further development and application of this
technology to the study of the nervous system has not been de-
scribed until now.
Here, we adapted microengraving to detect A and sAPP
from single living neuronal and glial cells derived from iPSCs.We
identified subpopulations of cells that secrete high levels of sAPP
and/or A, and these subpopulations were further characterized by
immunostaining and RNA profiling. We have found the following:
(1) a previously unappreciated subpopulation of cells that secrete
high levels of A in the absence of detectable sAPP; (2) during the
time of neural differentiation, the number of cells secreting detect-
able levels ofAand sAPP increases; and, intriguingly, (3) that cells
expressing forebrain GABAergic neuronal markers are overrepre-
sented in subpopulations of cells that secrete high levels of A and
sAPP, although varieties of cell types can secrete high levels of each.
Finally, although there is a widespread belief that neurons are the
major source of A in the CNS, the results presented here show that
astrocytes are competent to secrete high levels of A and therefore
have thepotential tobea significant contributor toAaccumulation
in AD. Together, the results presented regarding A and sAPP
secretion from hiPSC-derived neural cells at a single-cell level dem-
onstrate the utility of such a system to address previously intractable
questions regarding secretion of analytes relevant to nervous system
function and pathobiology.
Materials andMethods
Chemicals and antibodies. Cells were stained with the live marker calcein
violet AM or calcein red-orange AM according to manufacturer’s instruc-
tions (Life Technologies). Antibodies used in microengraving included
anti-A (6E10, Covance; 266, Elan Pharmaceuticals), anti-APPN terminus
(22C11; Millipore), and anti-APP N terminus (4F2; Selkoe Laboratory,
BrighamandWomen’sHospital). Selecteddetectionantibodies (4F2or266)
were conjugatedwithHRPor biotin, respectively, by Lightning-linkHRPor
Biotin antibody labeling kits (Novus). Cy2-conjugated anti-HRP and Cy3-
conjugated anti-biotin were purchased from Jackson ImmunoResearch.
Cell culture. CHO cells stably overexpressing human wild-type APP
(7WD4 cells; Xia et al., 1997) were cultured in Dulbecco’s Eagle medium
supplementedwith10%fetal bovine serumand500g/mlG418 (LifeTech-
nologies). Cells were dissociatedwith 0.25%Trypsin/EDTAandneutralized
with culturemedium.After centrifugation to remove trypsin, cells were sus-
pended in fresh medium at 1–2 105 cells/ml and plated for printing for
sAPP and A.
Healthy control (YZ1, TZ1, YK26) or fAD (APP V717I) iPSC-derived
forebrain neurons (2 female and 2male) were cultured and differen-
tiated according to the described protocol (Muratore et al., 2014a; Mu-
ratore et al., 2014b). In brief, an embryoid aggregate method was used to
generate aggregates, which were then plated onMatrigel-coated plates at
day 7 of differentiation. This differentiation protocol generates neurons
and glia of multiple cortical fates. To enrich for the differentiation of
these cells to GABAergic interneuron fates, sonic hedgehog protein
(R&DSystems) was added to cultures (1000 ng/ml) at the neural progen-
itor stage between days 11–26. At day 26 of differentiation, neuronal
aggregates were plated onMatrigel-coated plates for final differentiation
and fed with neural differentiation medium containing N2, B27, and
growth factors cAMP, IGF1, BDNF, and GDNF.
PDMS arrays used with iPSC-derived neural cells were coated with 5
g/ml laminin and 20g/ml poly-ornithine (Sigma-Aldrich) for 30min
and then blocked with Dulbecco’s Eagle medium supplemented with
10% fetal bovine serum for 30 min before cell plating. A suspension of
1–2  105 cells/ml of dissociated iPSC-derived neural cells were plated
on the precoated PDMS at the days of differentiation listed in the text and
then cultured overnight before 4 h printing for sAPP and A. Puri-
fied human astrocytes were purchased from ScienCell and cultured in
ScienCell’s “astrocyte medium.”
Microengraving and printing. The nanowell arraywas fabricated from a
biocompatible PDMS (polydimethylsioxane) affixed to a glass micro-
scope slide. Each array had 84,672 wells with 50 50 50 m dimen-
sions. Before cell plating, PDMS arrays were incubated in a vacuum
plasma cleaner at a high radio frequency for 2 min to make the surface
hydrophilic for later cell plating and then placed in PBS. Cells were
loaded from suspension (1–2  105 cells/ml) by gravity, which favors
0–2 cells per well (examined in real-time under a microscope). Nonad-
herent cells are removed through subsequent washing. The cells on
PDMS were stained with calcein violet or calcein red-orange (Life Tech-
nologies) and imaged using an automated inverted epifluorescence mi-
croscope (Zeiss). Cell viability and numbers per well were analyzed with
Enumerator software (custom software, available upon request to J.C.L.;
Ogunniyi et al., 2009; Han et al., 2010). Capture antibody for sAPP and
A (6E10) (35 g/ml) and human IgG antibody (15 g/ml) were coated
onto a poly-lysine-coated glass slide at room temperature for 1 h and
blocked with 5% BSA in PBS for 30 min. Before printing, the glass slide
was briefly incubated with 10,000 diluted human serum. Detection of
human serum bound to human IgG antibody allows for software align-
ment of wells. The coated slide was used to seal the nanowell array plated
with cells (clamped between plates using a microarray hybridization
chamber). Incubation time of printing varied between 2 and 4 h (see
results section) at 37°C, followed by removal of the glass slide. Captured
sAPP and total A on the glass slide were detected by incubation with
HRP- or biotin-conjugated detection antibodies for 1 h at room temper-
ature (RT), followed by a fluorescently labeled secondary antibody at RT
for 1 h. Fluorescent signals were detected using a Genepix Pro slide
scanner and aligned with Crossword (Gierahn et al., 2014). Secretion
data from Crossword and cell information from Enumerator were com-
bined according the unique ID for each well. For differentiated human
iPSC cells, wells were deemed analyte positive if the signal was 1 SD above
themean and the intensity of30%of the pixels within the well area was
2 SDs above the local mean background intensity.
Immunostaining of cells in arrays. After analyte detection, human
iPSC-derived neural cells were fixed with 4% paraformaldehyde for 30
min and then blocked in PBS/2% Donkey serum/0.1% Triton X-100 for
1 h. After blocking, the cells were immunostained with a variety of anti-
bodies such as Tuj1 (1:200; Millipore), GFAP (1:1000; Abcam), APP N
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terminus antibody (4F2; 1:500), APP C terminus antibody (C9; 1:500),
FoxG1 (1:200; Abcam), Tbr1 (1:200; Abcam), glutamate (1:1000; Immu-
nostar), and GABA (1:1000; Immunostar). A list of cell information
including thewell IDs, cell size, and fluorescent intensities were extracted
using Enumerator software and then gated using MATCH box software
(Gierahn et al., 2014) to identify cells positive for eachmarker. Randomly
chosen images of cells were extracted and visually confirmed for proper
assignment of “negative” or “positive.” The cytometry data were then
merged with microengraving data to assign occupancies and correlate
imaging cytometry data with secreted protein data for each well.
Single-cell NanoString gene expression analysis. Individual human
iPSC-derived neural cells of interest, identified by microengraving, were
stained with trypan blue for viability assessment and retrieved using a
CellCelector micromanipulator (Automated Lab Solutions). The re-
trieved cells were transferred into lysis buffer (Single Cell-to-CT kit; Life
Technologies) followed by reverse transcription (SuperScript Vilo Mas-
Figure 1. Overview of the protocol for detecting secreted APP cleavage products from single cells. In the first step, cells are dissociated, plated in nanowells, stained with a viability marker
(calcein), and imaged. In the second step, wells are sealed off from their neighbors with a glass slide coated with a capture antibody that binds both sAPP and A, as well as a control antibody
(human IgG) for highlighting the shape and precise location of each well. Secreted sAPP and A are captured for 2–4 h. After incubation, the glass slide is separated from PDMS wells and then
incubated with HRP- or biotin-conjugated detection antibodies for sAPP and A, followed by fluorescence-conjugated secondary antibodies. The glass slide is then washed and scanned using a
Genepix scanner. In the third step, the cells in PDMSwells aftermicroengraving are either fixed and immunostained for cell fatemarkers or retrieved fromwells for gene expression analyses. Finally,
data from each step are integrated and analyzed using Crossword and Matchbox.
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terMix; Life Technologies) and multiplexed
target enrichment (30 cycles) for genes con-
tained in a custom 150-gene NanoString code-
set. Next, 2 l of amplified samples were
loaded withHTDNA 5K LabChip kit on a Cal-
iper LabChip GXmachine to examine amplifi-
cation of cDNA products. Only single-cell
samples having clearly amplified products be-
tween 200 and 400 bpwere furthered examined
using the NanoString assay. The amplified
cDNAwere hybridized to the code set and pro-
cessed with the nCounter Prep station as per
the manufacturer’s instructions. The cartridge
was scanned using the nCounter Digital Ana-
lyzer and analyzed by nSolver Analysis Soft-
ware. Raw probe counts were normalized to
total probe counts per sample. Heat map and
principle component analysis (PCA) were per-
formed using the Genepattern platform estab-
lished by the Broad Institute.
Results
Detection of A and sAPP secreted
from single cells overexpressing APP
To examine secretion of analytes from
single cells, cells were plated from a sus-
pension in definedmediumonto arrays of
nanowells with volumes of 50m3. These
arrays were manufactured by replica
molding using a biocompatible elastomer
(Ogunniyi et al., 2009). The density of
cells plated favors 0, 1, or 2 cells in each
well (12 105 cells/ml). Approximately
100,000 wells are analyzed per assay, with
30,000–40,000 wells containing single
cells. Wells with two or more cells can be
analyzed separately and wells with no
cells aid in background determinations.
Figure 1 presents an overview of the mi-
croengraving procedure. After plating in
nanowells, cells were stained with a
marker for living cells and imaged. After
imaging, analyte secretion was examined
by placing glass slides coated with capture
antibodies to analytes of interest on top of
the nanowell array. These slides isolate
each well from its neighbors and create
microenvironments with 100 pl of me-
dia per well. The subnanoliter volume of
the well enhances the sensitivity of the as-
say relative to conventional methods. Af-
ter analytes were captured over 2–4 h, the
glass slides were removed and incubated
with a detection antibody conjugated to
an HRP or biotin tag, followed by a
fluorescence-conjugated anti-HRP or
anti-biotin, similar to a traditional “sand-
Figure2. Single-celldetectionofAPPcleavageproductsusinghumanAPP-overexpressingstableclonal cell lines.Microengravingwas
used to co-detect secreted A and sAPP from CHO cells overexpressingwild-type hAPP (7WD4).A,B, Representative histogramdistri-
butions of sAPP andA fluorescence intensity fromwellswith orwithout cells from single arrays.C, Representative printing images for
4
single blocks of nanowells. Yellow arrows highlight the range
of intensities for printing observed from single living cells. D,
Fluorescence intensities (SNR) are plotted for sAPP (x-axis)
and total A ( y-axis) for each well with positive signal. Each
dot represents data from a single well containing 1–4 cells.
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wich ELISA.” Slides were scanned and analyzed using standard
microarray instrumentation (Genepix). After removal of the
slides, cells remained in their original nanowells and were stained
with a second live cell marker, fixed and immunostained, and/or
retrieved from the nanowell for examinations of gene expression.
Data were analyzed using both Genepix and MATCH Box soft-
ware and integrated to provide compiled data for each cell as
described previously (Gierahn et al., 2014). To control for vari-
able background levels across the array, data are presented as the
signal-to-noise ratio (SNR), calculated as follows: SNR (fore-
ground median  background median)/(STDEV background).
To gauge our limit of detection for A and sAPP codetection,
spot blots were performed using purified A and sAPP and
optimized antibody pairs. A and sAPPwere detected at a con-
centration as low as 1 ng/ml using our detection method.
We first examined the efficiency of A and sAPP co-
detection from single cells using microengraving with a stable
monoclonal CHO-based cell line overexpressing wild-type hu-
man APP (7WD4; Xia et al., 1997). With this CHO-based cell
line, 74.3% (2.9 SEM) of cells stained positive for a “live” cell
Figure 3. Gene expression and viability after culture of hiPSC-derived neurons and glia after culture in nanowells. A, Schematic of timing of hiPSC neural differentiation (Muratore et al., 2014a;
Muratore et al., 2014b).B–D, HiPSC-derived neural cells in pooled cultures (d98) were either lysedwithout dissociation, dissociated and lysed 1 h later, or dissociated and lysed 24 h later. RNAwas
preppedand subjected toNanoString analysis. Normalizeddata for genes relating toAPP cleavage (B), neuronalmarkers (C), andglial andNPCmarkers (D) are shown.n3 for each condition, error
bars indicate SD.E, Viability of single hiPSC-derivedneural cells over differentiation time is shown.n2 (d20–50), 7 (d51–80), 4 (d81–110), 2 (d111–130), and14 (7PA2). Error bars indicate SEM.
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Figure 4. Detection of secreted sAPP and total A from single hiPSC-derived neural cells. Human iPSCs were differentiated to forebrain neural fates. Atmultiple time points of differentiation,
cells were dissociated and plated in nanowells for 24 h. Cells were then imaged for a marker of living cells and sAPP and A detected using the experimental outline presented in Figure 1. The
detection efficiency for single, living cells is shown for sAPP (A) and A (B) at different time points of differentiation and compared with the detection efficiency for 7WD4 cells over multiple
experiments: iPSC differentiation d20–50 (n 4), d51-d80 (n 5), d81-d110 (n 4), and 7WD4 (n 13). Box shows minimum to maximum value and line shows (Figure legend continues.)
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marker (calcein violet) following the entire procedure. Figure 2,
A andB, showhistograms of the relative frequency for sAPP and
A detection from wells with no cells, cell-containing wells that
we determined are below the threshold of detection for each ana-
lyte (“neg”), and cell-containingwells that were above the thresh-
old of detection for each analyte (“pos”). To be called “positive,”
the intensity of the signal from the well must be 1.5-times the
local background plus 2 SDs. These results show that, using these
methods, we can accurately separate positive and negative sig-
nals. To minimize the rate of false discovery, we used stringent
criteria for calling a signal “positive” and are therefore likely call-
ing some wells “negative” that are actually secreting analytes
above the technique’s threshold of detection (see red vs blue his-
togram traces in Fig. 2A,B). To estimate a false-positive rate, we
examined the percentage of wells containing no cells that were
deemed to be positive by our stated criteria. Over 12 experiments,
the estimatedmean percentage of “false positives” based on these
criteria was 0.10% for sAPP and 0.02% for A.
Figure 2C shows representative blocks from two arrays for the
range of signal intensities observed for total A and sAPP code-
tection (7WD4 cells). Yellow arrows point to individual wells to
highlight different fluorescent intensities observed from this
monoclonal cell line when these cells were analyzed at the single-
cell level. Figure 2D highlights this further, showing the relative
range of secretion levels from wells with single cells (red dots).
The presence of multiple cells in a well did not seem to influence
the relative secretion of total A and sAPP significantly (Fig.
2D). These analyses of single cells suggest that, even in a popula-
tion homogenous in cell fate, cell state (e.g., cell cycle phase) may
affect secretion of these APP cleavage products.
Detection of A and sAPP in single human iPSC-derived
neurons and glia
In recent years, numerous studies including our own have estab-
lished protocols for differentiating human iPSCs to neuronal and
glial fates of the forebrain (Muratore et al., 2014a;Muratore et al.,
2014b). Figure 3A outlines the developmental timing of our dif-
ferentiation protocol, which results in90% of the cells express-
ing neuronal markers at day 40, with a portion of the remaining
cells expressingmarkers of neural progenitor cells. These progen-
itor cells produce astrocytes late in the differentiation protocol
and, by day 100 of differentiation, 75% of the cells express
neuronal markers and 20% express astrocyte markers (Mura-
tore et al., 2014b). The population expressing neuronal markers
consists of a heterogeneousmixture of cells expressingmarkers of
upper and lower cortical layers, as well as markers of excitatory
and inhibitory neurons. We have shown previously that these
heterogeneous mixtures of neural cell types secrete increasing
levels of A and sAPP over differentiation time from day 0 to
day 100 (Muratore et al., 2014b). This suggests that APP expres-
sion and/or processing increases as cells go from an immature,
mitotic fate to a postmitotic, differentiated neuronal state. Using
the MSD ELISA platform, we estimated the levels of A and
sAPP secreted from pooled populations of hiPSC-derived neu-
rons and glia between days 50 and 100 to be 50–1800 pg/ml of
total A and 15–110 ng/ml sAPP (Muratore et al., 2014b). Nor-
malizing to the estimated number of cells plated in the pooled
cultures (30,000 cells per well) and the amount of time themedia
were conditioned (48 h), we estimate that the mean levels of
secretion per cell over 4 h (a standard time that we captured
analytes using microengraving) is 0.1–5.0 fg of total A and 50–
300 fg of sAPP. However, it is clear that every cell is not secreting
equal amounts over 4 h. Given the heterogeneity of cell fates
present in these cultures, we predict that subpopulations of cells
are contributing more or less to the levels of A and sAPP
secreted within a given 4 h window.
To adapt microengraving for analyses of neural cells, neurons
and glia were derived from iPSCs using our established protocol
(schematized in Fig. 3A; Muratore et al., 2014b) and then disso-
ciated and plated cells in nanowells at multiple time points. We
found significant changes in the expression of a subset of genes
acutely after dissociation, which rebounded to original levels 24 h
after dissociation (Fig. 3B–D). These acute changes are not sur-
prising given the physical and chemical manipulation of the cells.
We thus measured secreted analytes 24 h after dissociation and
plating in nanowells.We have comparedmethods of dissociating
hiPSC-derived neurons and found that Accutase (Innovative Cell
Technologies) effectively dissociates these cells whilemaintaining
high cell viability. We next determined the optimal substrate for
plating these cells in nanowells by comparing PDMS without
additional substrate with poly-D-lysine coating or with poly-
ornithine/laminin coating. We found that poly-ornithine/
laminin provides the optimal viability and lowest background.
Over the time allowed for differentiation, the viability of the cells
after dissociation and plating in nanowells does not appear to
vary significantly (Fig. 3E). However, the detection prevalence of
both total A and sAPP increases over differentiation time from
day 20 to day 110 (Fig. 4A,B). Although the detection prevalence
increases over differentiation time, the distribution of SNRvalues
of analyte “positive” single cells does not vary significantly be-
tween these time points (Fig. 4C,D). Figure 4, E and F, show
histograms of the relative frequency for A and sAPP printing
intensities for wells with no cells, cell-containing wells that we
determine were below the threshold of detection for each analyte
(“neg”), and cell-containing wells that were above the threshold
of detection for each analyte (“pos”). Similar to experiments in
7WD4 cells overexpressing APP (Fig. 2A,B), we were able to
identify secretion of these analytes accurately from single cells
above background fluorescence intensities (Fig. 4E,F).
A range of secretion profiles for A and sAPPwere observed
from differentiated neural cells (90 d of differentiation; Fig.
4G–I). Although subsets of cells secrete detectable levels of both
A and sAPP, a larger subset of cells secretes detectable levels of
only sAPP. This is to be expected because-secretase cleavage is
a higher-frequency event than -secretase cleavage in most cell
types, including hiPSC-derived neural cells. Over hiPSC differen-
tiation in pooled groups of cells, the : cleavage ratio is20 at
d9 of differentiation and this ratio steadily decreases to 2 at
d100 of differentiation (as measured by sAPP vs sAPP release
from cells; Muratore et al., 2014b). Both - and -cleaved APP
products steadily increased over differentiation time as total APP
expression increased. Despite the observed predominance of
4
(Figure legend continued.) themedianvalue. **p0.01, Kruskal–Wallismultiple-comparisons
test. C, D, Histogram distribution of SNR values of wells positive for sAPP (C) and A (D) for
each range of differentiation time. For each bin, data from three independent experiments for
each time point are combined. Histogram distribution of the relative frequency of sAPP (E)
and total A (F) SNR printing intensity from wells with or without cells are shown (combined
data from three representative experiments, each over 75 d of differentiation). G–I, Combined
data from four experiments are shown for single, living cells differentiated to neuronal fates for
64–99 d. The intensity of sAPP or A secreted from three different groupings of single cells
(sAPP/totalA	, sAPP	/totalA, sAPP	/totalA	) are presented in G and H
and the correlation of sAPP and total A fromeachgroup is presented in I. Black lines inG and
H denote the mean value for each group. ****p 0.0001, one-way ANOVA, Kruskal–Wallis
multiple-comparisons tests.
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-cleavage, we also observed a smaller but unexpected subpopu-
lation of cells that secreted detectable levels of Awithout detect-
able levels of sAPP (Fig. 4G–I). Over five independent
experiments, the percentage of the total population of cells that
secreted high A without detectable sAPP ranged from 0.03%
to 0.10% (mean of 0.7% 0.4% SD). Cleavage of APP via - or
-secretase is believed to occur, respectively, at the cell surface
and in acidic compartments such as endosomes. Additional stud-
Figure 5. HiPSC-derived neural cells from familial AD and healthy control lines display similar secretion profiles of A and sAPP. Control and fAD hiPSC lines were differentiated to neural fates
for 121 d, followed by dissociation, labeling with calcein violet (control) or calcein red-orange (fAD), and were then mixed and plated in nanowells and imaged. Twenty-four hours later,
microengravingwas performed for 4 h to detect sAPP and A, followed by stainingwith a second viability marker and imaging. Histograms show the distribution of SNR values of wells negative
or positive for sAPP (A) and total A (B). For each graph, data from three arrays are combined. C,D, Fluorescence intensity of sAPP (C) or total A (D) secreted from three different groupings of
single cells (sAPP/totalA	, sAPP	/totalA, sAPP	/totalA	). Black lines in C and D denote the mean value for each group. *p 0.05; ****p 0.0001, ns not significant,
one-way ANOVA, Kruskal–Wallis multiple-comparisons tests. The correlation of sAPP and total A fluorescence intensity from each group for control (E) and fAD (F) is shown. Percentages of
subpopulations defined by different sAPP and A secretion profiles were calculated for control and fAD hiPSC-derived neural cells and graphed as pie charts in G. ***p 0.001, chi-square tests
comparing fAD with control (expected).
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Figure 6. Examination of gene expression profiles after detection of sAPP and A from single iPSC-derived neural cells. HiPSC-derived neural cells differentiated to neural fates90 d were
stainedwith calcein (violet for control cells or red-orange for fAD cells) tomark viable cells and imaged, followedby4hofmicroengraving for sAPP and total A. After printing, individual cellswere
stainedwith trypan blue tomark cells with intactmembranes, retrieved fromnanowells, lysed, and cDNAwas synthesized and amplified usingmultitarget amplification and hybridized to a custom
NanoString codeset. Expression data for each cell was normalized to total probe counts. A, Example images of cells from wells selected for NanoString analysis and their corresponding printing
images are shown. BF, Bright field; IgG, control to aid inwell alignment.B, Heatmap of expression data of select genes are shown for each cell, as well as for pools of 500 cells each. Full datasetwith
normalized values are presented in the GEO database (http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?accGSE76551). C, PCA (GenePattern) was performed, the top two eigenvectors graphed,
and subgroups colored based upon neuron and astrocyte marker expression (left) and APP cleavage product secretion (right).
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ies are warranted to examine the mechanism by which this rare
population of cells displays elevated -cleavage relative to
-cleavage. This single-cell technology provides an opportunity
to address this important question. Interestingly, when compar-
ing cells that secrete detectable levels of sAPP alone with cells
that secrete detectable levels of both analytes, the mean levels of
secreted sAPP levels were elevated when detectable levels of A
were also secreted (Fig. 4G). In contrast, mean levels of A were
not different between A positive groups (Fig. 4H).
Comparison of A and sAPP secretion from neural cells
derived from control and familial AD iPSCs
Wehave reported previously the generation and characterization
of hiPSC lines from fADpatients harboring the Londonmutation
in APP (V717I; Muratore et al., 2014b). In that study, we con-
firmed the known effect of this mutation on increasing the A42
to A40 ratio in pooled cultures. In addition, we found that
overall levels of secreted A were slightly but significantly ele-
vated in fAD neural cultures relative to control cultures due to
elevated -secretase cleavage (1.5-fold increase in total A lev-
els as measured by ELISA; Muratore et al., 2014b). Here, we
aimed to compare A and sAPP secretion profiles from control
and fAD single neural cells. Control and fAD iPSCs were differ-
entiated to neural fates in parallel cultures for 90 d as above.
Cells then were dissociated and differentially labeled with calcein
violet (control) or else calcein red-orange (fAD). Cells were then
mixed and plated in nanowell arrays. Secreted A and sAPP
were detected as in Figure 1. Histograms in Figure 5, A and B,
show that the distribution of sAPP and A fluorescence inten-
sities from both control and fAD cells are highly similar. Further,
of the cells secreting detectable levels of sAPP and A (Fig.
5C–G), the levels of each analyte in each subpopulation
(sAPP/A	, sAPP	/A; sAPP	/A	) were similar
between control and fAD cells, with fAD cells showing slightly
higher averaged levels of A secretion. The percentage of cells
secreting detectable A was 1.4-fold higher in fAD cells. In
addition, a higher proportion of the fAD population secreted
detectable levels of A (expected distribution based on propor-
tions from control population, 2 test, p 0.001). Therefore, the
elevated A levels in fAD neural cells observed in pooled cultures
(Muratore et al., 2014b) appears to be due in part to increased
numbers of cells secreting high levels of A.
Profiling of subpopulations of hiPSC-derived neurons and
glia secreting the highest levels of A and sAPP
As discussed above, measurements of A and sAPP secretion
from iPSC-derived neural cultures using standard tissue culture
techniques have revealed differences in APP cleavage over differ-
entiation time. Although these observations were consistent be-
tween wells containing pools of cells, differentiation rounds, and
cell lines, these data represent data from bulk heterogenous pop-
ulations of multiple cell fates. It is unknown whether cells of
particular neuronal and glial fates process APP differentially and
if there are specific cell fates that contribute predominantly to
the observed secretion profiles of A and sAPP. Therefore,
we next aimed to identify the subpopulations of cells in hiPSC
neural cultures that secrete the highest levels of A and/or
sAPP, and molecularly characterize those cells. Control and
fAD human iPSCs were differentiated to neural fates for90 d
and A and sAPP detected as in Figure 5. Cells were stained
for trypan blue after printing and selected viable cells were
analyzed by gene expression analyses. Individual cells secret-
ing both analytes, sAPP alone, or neither analyte were re-
trieved from their nanowells and lysed. RNA was reverse-
transcribed using SuperScript VILO Mastermix and cDNA
amplified 30 using multiplexed enrichment of each of 150
targets sequences. Amplified cDNA was then denatured and
hybridized to a custom NanoString codeset. In parallel, sets of
500 cells were lysed and subjected to the same protocol
(“pools”). Data obtained were normalized to the total probe
counts per cell (or pool of cells). Figure 6A shows the A and
sAPP printing images from examples of the cells selected for
NanoString analysis. This custom probe set contains cell fate
markers, housekeeping genes, APP and its binding partners,
and genes encoding the secretases that cleave APP. Heat
map of normalized Nanostring data are shown in Figure 6B.
These experiments were replicated in an independent set of 29
cells on a separate custom Nanostring probe set targeting an
overlapping set of genes. Normalized probe counts for each
gene for both sets are provided online in the GEO database
(http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?accGSE76551).
Neurons are thought to be themajor source of A in the brain
based on studies in mice (Zhao et al., 1996; Calhoun et al., 1999)
and expression of BACE (Vassar et al., 1999; Laird et al., 2005).
Furthermore, there is evidence that excitatory neurons of the
forebrain are a strong contributor of A secretion through an
activity-dependent mechanism (Kamenetz et al., 2003). There-
fore, we hypothesized that, at the single-cell level, the highest
secretors of A would be neurons and perhaps a particular sub-
type of excitatory neurons. However, individual cells secreting
sAPP and/or A expressed markers for astrocytes or neurons
(Figs. 6B, 7B,E). Within the class of cells expressing neuronal
markers (“neuron-like” cells), markers of GABAergic (e.g., P10,
O14) and glutamatergic (e.g., P6, O6), as well as of upper (e.g.,
P15, O1) and lower (e.g., P5, O6) layer neuronal fates were ex-
pressed in subsets of individual cells secreting high levels of
sAPP and/or A (Figs. 6B, 7C,F).
In agreement with our observations of individual genes, prin-
ciple component analysis (PCA) of the NanoString dataset did
not segregate cells based upon sAPP and A secretion profile
(Fig. 6C). Based upon the expression of the top 10 genes in each
cell, we classified each cell as “neuron-like,” “astrocyte-like,” or
“NPC/mixed” and PCA-segregated cells based upon this clas-
sification scheme (Fig. 6C). Cells secreting the highest levels of
sAPP and A were represented in each of these subgroups
(Fig. 6C).
In recent years, several candidate protein ligands for APP,
including F-spondin (Ho and Su¨dhof, 2004; Hoe et al., 2005),
Reelin (Hoe et al., 2006; Hoe et al., 2009), Integrin 1 (Young-
Pearse et al., 2008), Contactins (Bai et al., 2008; Osterfield et al.,
2008), Lingo-1 (Bai et al., 2008), andPancortins (Rice et al., 2012)
have been reported to interact physically with the ectodomain of
APP and modulate its processing—and, in some cases, function.
In addition, several cytosolic proteins, including DAB1 (Homay-
ouni et al., 1999; Young-Pearse et al., 2007), PICALM (Xiao et al.,
2012), DISC1 (Young-Pearse et al., 2010), Fe65 (Borg et al., 1996;
Zambrano et al., 1998; Cao and Su¨dhof, 2004), MINTs
(McLoughlin and Miller, 1996; Mueller et al., 2000; Hill et al.,
2003), and SORLA (Cam and Bu, 2006), have been identified to
bind to the intracellular domain of APP and expression of several
of these proteins has been described to affect APP trafficking
and/or cleavage. Because many of these APP-binding partners
were shown to affect- and/or-secretase cleavage,we examined
expression of these factors in cells secreting APP cleavage prod-
ucts (Fig. 7). On average, cells secreting high levels of A ex-
pressed lower levels of total Pancortin (Fig. 7G), but relatively
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Figure 7. Cells secreting high levels of sAPP and A express markers of an array of cell types. Scatter plots of data for select genes examined by NanoString analysis in Figure 6: APP (A), Tuj1
(B), VGLUT1 (C), BACE1 (D), GFAP (E), VGAT (F), Pancortin (M;G), MINT2 (H), Pancortin (A; I), andMINT3 (J). *p 0.05, ***p 0.001, one-way ANOVAwith Kruskal–Wallis multiple-comparisons
tests performed across single-cell data.
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higher levels of a particular isoform of Pancortin (A-domain; Fig.
7I). The majority of cells secreting high levels of sAPP also
expressed high levels of MINT2 (Fig. 7H), whereas MINT3 was
highly expressed in cells not secreting high levels of either analyte
(Fig. 7J). Although potentially interesting and worthy of further
analyses, these data suggest that expression of these APP-binding
partners does not strictly define those subpopulations of cells
secreting high levels of A and/or sAPP.
We predicted that cells secreting the highest levels of APP
cleavage products would express the highest levels of APP and
those secreting Awould express the highest levels of-secretase
(BACE1 and/or BACE2). Although the average RNA levels of
APPwere significantly higher in cells secreting detectable levels of
both analytes (Fig. 7A), BACE expression levels were not predic-
tive for whether a cell would secrete detectable A (Fig. 7D).
Although some A-secreting cells expressed low levels of BACE,
other cells that did not secrete detectable APP cleavage products
expressed very high levels of BACE and APP. Similarly, expres-
sion of genes encoding - and -secretase did not segregate with
any particular APP analyte subgroup (Fig. 6B). This result sug-
gests that, at a single-cell level, RNA expression levels of APP and
its cleavage enzymes are not predictive of high levels of APP cleav-
age product secretion. It would be valuable to examine other -,
-, and -cleaved products using this methodology in future
studies to assay activity of these secretases in parallel to APP
processing. This methodology also provides insights into the
complement of ADAMs, BACEs, PSENs, and aph1 isoform ex-
pression in subsets of iPSC-derived neural cells. For example,
some cells secreting sAPP express ADAM10, whereas others
express ADAM9, ADAM17, or combinations of these ADAMs.
(Please see theNanostring data in theGEOdatabase: http://www.
ncbi.nlm.nih.gov/geo/query/acc.cgi?accGSE76551.)
To examine APP at the protein level, we immunostained
hiPSC-derived neural cells with antibodies recognizing both the
N- andC termini of APP after printing forA and sAPP (Fig. 8).
Greater than 80% of the cells in the overall population and in the
A- and sAPP-secreting subpopulations were positive for im-
munostaining with both antibodies. Six percent of A-secreting
cells (14/239) and 3% of sAPP-secreting cells (26/875) immu-
nostained negative for both epitopes. We hypothesize that this
small subset of cells that express low levels of APP holoprotein
but secrete high levels of cleavage products represent a subpopu-
lation of cells that cleave APP holoprotein in a highly efficient
manner.
To evaluate the validity of cell fate findings in larger number of
cells, we performedmicroengraving experiments followed by im-
munostaining for cell type markers. Figure 8A shows printing
and immunostaining examples of individual wells. Approxi-
mately 70% and 11% of the overall population of cells were
TUJ1	GFAP andTUJ1GFAP	, respectively. Eleven percent
of the cells expressed neither marker and may represent neural
crest or neural progenitor cells. The remaining 8% of cells were
positive for both markers (co-expression of these genes also was
observed in a subset of cells at the RNA level, a population we
called “mixed/NPC”; Fig. 6C). The populations of cells secreting
detectable levels of A and/or sAPP had profiles of TUJ1 and
GFAP expression highly similar to the total population, with a
slight overrepresentation of the TUJ1	GFAP subpopulation
(Fig. 8C). To verify that astrocytes are indeed capable of secreting
high levels of A, we examined the secretion profile of A and
sAPP from purified human astrocytes obtained from ScienCell.
At the single-cell level, a subset of these astrocytes secreted detect-
able levels of sAPP (8.8%  3.2 SD of the total population of
cells) and A (1.6%  1.0 SD of the total population of cells),
with a similar profile of secretion as hiPSC-derived cells (Fig.
9A–D). At the pooled level, these primary astrocytes secreted A
species at1/3 the level of hiPSC-derived neural cells at day 60, as
measured by standard MSD ELISA (Fig. 9E,F). These findings
suggest that both neurons and astrocytes are capable of secreting
high levels of each of these analytes.
To further examine whether certain subtypes of neural cells
preferentially secrete high levels of APP cleavage products, after
A and sAPP detection, parallel arrays were immunostained
either for FOXG1 (a forebrain progenitor and neuronal marker)
and TBR1 (amarker of subsets of progenitor cells as well as lower
cortical layer neurons) or for glutamate and GABA. Relative to
the total population of cells, FOXG1	TBR1	 cells were overrep-
resented in the sAPP	 subpopulation of cells (5465/10141 cells;
54% of total population vs 525/729 cells; 72% of sAPP	 cells;
Fig. 8C). In addition, GABA	 cells were mildly but significantly
overrepresented in the sAPP	 andA	 subpopulations (1038/
2156 cells; 48% and 283/714, 40%, respectively) relative to the
overall population of cells (11332/33215 cells, 34%; Fig. 8C).
To examine A and sAPP secretion from an interneuron-
enriched iPSC-derived population, we used sonic hedgehog
(Shh) to direct forebrain cortical neurons to a more ventral fate
during a critical patterning window (Fig. 10A). Previous reports
have shown that treatment with Shh during this window directs
cells to a GABAergic, interneuron fate (Liu et al., 2013). As re-
ported previously (Liu et al., 2013), we observed that treatment
with Shh during this window reduces expression of a marker of
excitatory cortical neuron fates (TBR1; Fig. 10C) and increases
expression of markers of interneuron fates (GAD1, GABA, PVB;
Fig. 10B,C). After differentiation to 40 d, media were collected
from pooled cultures and analyzed by standard MSD ELISA.
Neural cultures that had been patterned with Shh showed 2-
fold elevated levels of secretion of A38, A40, and A42 relative
to unpatterned neural cultures (Fig. 10D).
Discussion
In this study, we have established amethodology for detectingA
and sAPP secretion from single cells. We have adapted this
method to examine secretion of these analytes fromhuman iPSC-
derived neurons and astrocytes and show that we can interrogate
intrinsic characteristics of secreting cells using immunostaining
and RNA expression analyses. Because of its central role in AD
pathogenesis, the mechanism by which APP is cleaved has been
the focus of a multitude of studies in academia and industry.
Therefore, much is known about small molecules and protein
factors that regulate APP cleavage by -, -, and -secretases.
This deep knowledge base regarding APP cleavage provided an
ideal paradigm for establishing this methodology. In examining
A and sAPP secretion from single cells, wewere able to identify
previously unappreciated complexities in the biology of APP
cleavage that could not otherwise have been found by studying
averaged responses over pools of cells. First, we found heteroge-
neity in theA and sAPP secretion levels over 2 h fromwhatwas
thought to be a homogeneous populations of cells (clonal stable
APP-overexpressing CHO lines), suggesting that cell state can
have a detectable impact upon APP cleavage. Second, we show
that the observed increase in A and sAPP secretion in pooled
cells over differentiation time of human iPSC-derived neural cells
results from an increase in the number of cells secreting high
levels of each. Third, we predicted that distinct, molecularly de-
finable cell fates would secrete the highest levels of sAPP andA
and that subpopulations of glutamatergic, excitatory neurons
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would secrete the highest levels of APP cleavage products. By
examining iPSC-derived neurons and glia at a single-cell level, we
found instead that a diverse array of cell fates are capable of secreting
high levels ofA and sAPP, with a significant fraction of these high
secretors expressing markers of astrocytes or GABAergic neuronal
fate. These data support amodel inwhichmany distinct cell types in
the brain contribute to the pools of secreted A and sAPP. This
directly supports recent findings that revealed thatneuronsnotof an
excitatory fate, as well as non-neuronal cells, contribute robustly to
A generation and deposition in an aged transgenic model of AD
(Veeraraghavalu et al., 2014).
As with any experimental system in which the cellular envi-
ronment is perturbed, there are multiple caveats of this system to
keep in mind when interpreting results. Studies of single cells in
which individual cells are isolated from their neighbors, such as
those described herein, may be particularly vulnerable to poten-
tial artifacts. Here, we were careful in our interpretations to not
make claims regarding what occurs in the aged brain. Rather, we
highlight the potential of a variety of cell types to secrete high
levels of A, sAPP, or both analytes. For example, here, we
found that neurons expressing GABAergic markers can secrete
high levels of A. However, because other neuronal types also
secrete high levels of A, using microengraving alone it would
not be possible to predict what the impact of A secretion from
GABAergic cells would be in the living brain. Therefore, whereas
single-cell analyses provide a novel view of APP cleavage in indi-
Figure 8. Multiple cell fates are capable of secreting high levels of sAPP and total A. HiPSC-derived neural cells differentiated to neural fates90 dwere stainedwith amarker of living cells
(calcein violet) and imaged. Twenty-four hours later, cells were subjected to 4 h of microengraving for sAPP and A. After printing, cells were fixed in the nanowells and immunostained for the
listed factors. Example images of immunostained cells and their correspondingprinting images for sAPP and total A are shown inA.MATCHbox softwarewas used to plot fluorescence intensities
of individual cells. Cells were first gated for DAPI fluorescence (B, left) and the DAPI-positive cells were then gated for marker positivity (TUJ1 example shown in B, right). Percentages of
subpopulations defined by different immunostaining profiles were calculated for the total population, as well as the sAPP and the A printing positive populations, and graphed as pie charts in
C. For APP, “N” refers to anN-terminal antibodyand “C” refers to a C-terminal antibody. **p0.001, ****p0.0001, Chi-square tests comparing sAPPand total Aprintingpositive populations
compared with the total population (expected).
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Figure 9. Detection of secreted sAPP and A from primary human astrocytes. Human astrocytes (ScienCell) were dissociated and plated in nanowells. Cells were then imaged for a marker
of living cells and sAPP and/or total A was detected using the experimental outline presented in Figure 1. Histogram distribution of the relative frequency of sAPP (A) and A (B) SNR
printing intensity from wells with or without cells are shown. C, D, Intensity of sAPP or total A secreted from three different groups of single cells (Figure legend continues.)
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vidual cells, we want to emphasize the importance of validating
the potential significance of these findings with alternative
methods.
In this study, we have focused upon the secretion of analytes
from isolated individual cells. By examining single cells isolated
in nanowells, we can separate the intrinsically encoded properties
of A and sAPP secretion from the potential cell-non-
autonomous effects of cell–cell interactions. However, by care-
fully examining wells with two or more cells, this system has the
potential to dissect cell–cell interaction effects that may be im-
portant for APP processing. For example, we examined expres-
sion of a subset of proteins that have been proposed to affect APP
processing (Fig. 7). The effects of these and other proteins could
be tested at the single-cell level using a cell-mixing approach with
examination of wells with multiple cells. In addition, it has been
proposed previously that sAPP can affect APP processing (Ob-
regon et al., 2012). Data presented here in Figure 2D suggest that
multiple cells in a well do not affect the relative secretion of A
and sAPP in the case of a CHO cell line overexpressing APP.
Future studies are warranted to examine how particular cell types
of neural origin with endogenous APP expression influence APP
processing in other cell types of neural origin.
The method described here can be adapted to profile neural
progenitor cells, neurons, and glia that secrete other factors of
interest. Of particular interest are secreted proteins central to
neurodevelopmental processes and disease-relevant neurotoxic
4
(Figure legend continued.) (sAPP/totalA	, sAPP	/totalA, sAPP	/totalA	).
Black lines in C andDdenote themean value for each group. ****p 0.0001, nsnot significant,
one-way ANOVA, Kruskal–Wallis multiple-comparisons tests. E, F, Primary human astrocytes (E) or
elsehiPSC-derivedneural cells (F)were cultured in96-well plates at adensityof 40,000 cells perwell.
Conditionedmedia (CM)wascollectedafter incubationoncells for48handA levelsweremeasured
via ELISA.Mean values are shown for 6–7wells. Error bars indicate SEM.
Figure 10. HiPSC-derived forebrain cultures directed to ventral fates secrete elevated levels of A. Human iPSCswere differentiated to forebrain fates and culturedwith orwithout Shh between
days 10 and24 in standard culturing vessels (A). At day 40 of differentiation,mediawere collected after 48 h of culture and cells were either fixed and immunostained (B) or lysed and RNA collected
forqRT-PCRanalyses (C).B, Immunostaining formarkers of interneurons [GABA,parvalbumin (PVB)]withageneral neuronalmarker (MAP2)andcounterstainedwithDAPI. Imagesof Shh-patterned
neurons at day 40 of differentiation are shown. C, RNA was prepared and qRT-PCR was performed for a cortical marker (TBR1) or a marker of interneurons (GAD1). D, Media were analyzed by MSD
A triplex ELISA and normalized to total RNA (n 5). Error bars indicate SEM. ***p 0.001, ****p 0.0001, unpaired t test.
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species. In addition, because cells remain alive in the well after
printing, serial application of antibody-coated glass slides to the
arrays allows for longitudinal analysis of target analytes and
therefore allows for the investigation of responses of individual
cells to small molecules. Studies such as these may provide new
insights into the mechanism of action of certain small molecules.
In summary, we have established a method to detect analyte
secretion from hiPSC-derived single neural cells that allows us to
link this information to data collected about the cells. In optimiz-
ing this technique for detection of AD-related analytes, we have
uncovered novel biological findings that could not have been
observed without a single-cell analytical platform. These findings
open up a number of additional biological questions and this
technology provides an opportunity to elucidate the answers to
these questions. Importantly, this technique can be readily
adapted to the detection of other analytes secreted by neuronal
and glial cells. With the expansion to other analytes, this new
analysis platform has the potential to open new perspectives into
human CNS development and dysfunction.
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